Two traditional Chinese medicines complete clinical trials in Pakistan

By Staff Reporter | Gwadar Pro May 6, 2023

KARACHI, May 6 (China Economic Net) - Two traditional Chinese medicines, Houtou Jianweiling tablets and Fuke qianjin capsules, have completed clinical trials in Pakistan, according to results announced by a Pakistani clinical research body. 
Sindh Provincial Health Minister Dr. Azra Pechuho presented the test conclusion report of the randomized double-blind human clinical trials at a ceremony held in the International Center for Chemical and Biological Sciences (ICCBS) of the University of Karachi. 
The two clinical trials were conducted by the International Joint Laboratory of Traditional Chinese Medicine and Ethnic Medicine of Hunan University of Chinese Medicine (HUCM) and Sino-Pakistan TCM Clinic Research Center of ICCBS in Karachi. This is another breakthrough after HUCM promoted Yinhuang Qingfei Capsule to become the first Chinese patent medicine entering Pakistan in 2019.
A delegation of 16 Chinese researchers and industrialists from central China's Hunan Province visited Pakistan and participated in the event. They also participated in the dialogue for collaboration in the fields of traditional medicine, biotechnology and public health between China and members of the Organization of Islamic Cooperation (OIC).
Dai Aiguo, President of HUCM, said that the acceptance of Chinese medicine in Pakistan is increasing, and the cooperation between the two countries’ traditional medicines is gaining momentum. “In the future, the two sides will carry out exchange and cooperation in a greater scope, wider field and deeper level.” Dai said.
During the visit in the University of Karachi, HUCM and ICCBS discussed and exchanged views on the construction of Sino-Pakistan TCM Research Center, the Atta-ur-Rahman Academician Workstation and three other platforms. The two sides showed interest in cooperation and signed a cooperation framework agreement. 
“China and Pakistan have vast scope for cooperation in TCM. The successful trial of these two medicines in Pakistan marks a new achievement of HUCM’s International Joint Laboratory. It’s also a remarkable step that will promote cooperation in TCM between China and Pakistan,” Dai said.
This visit marks a new round of "ten-year engagement" since HUCM and ICCBS signed a cooperation agreement in 2013. Fruitful results have been achieved in scientific research, academic exchanges and personnel training between the two sides. More enterprises, experts and scholars will be engaged in this field in the future, according to HUCM.

  • comments
  • give_like
  • collection
More Articles